文献速递妇科肿瘤

宫颈癌前病变与浸润癌遗传变异的全基因组关联研究

Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
PubMed 文献 · Lancet Oncol · 2021-01-01

孟德尔随机化支持吸烟、首次妊娠年龄和性伴侣数量的因果作用。

要点

  • PAX8 rs10175462和CLPTM1L rs27069为新发现的宫颈癌易感位点。
  • HLA区域多个变异与CIN3及浸润癌强关联,提示免疫通路参与。
  • 孟德尔随机化提示吸烟和性伴侣数量增加、首次妊娠年龄增大影响风险。

核心结论

  • PAX8、CLPTM1L和HLA基因区域遗传变异与宫颈癌前病变及浸润癌易感性相关,涉及凋亡和免疫通路。

临床怎么用

  • PAX8、CLPTM1L和HLA区域变异可作为宫颈癌遗传易感性标志物,但仍需进一步验证。
  • 吸烟和性伴侣数量是宫颈癌的可干预风险因素,首次妊娠年龄较晚与风险降低相关。

局限性

  • 研究仅纳入欧洲人群,结果外推至其他种族需谨慎。
  • 孟德尔随机化分析依赖遗传工具变量假设,可能存在多效性偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to compare genetic variation in women with invasive cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 with that in healthy controls. METHODS: We did a GWAS in a cohort of unrelated European individuals using data from UK Biobank, a population-based cohort including 273 377 women aged 40-69 years at recruitment between March 13, 2006, and Oct 1, 2010. We used an additive univariate logistic regression model to analyse genetic variants associated with invasive cervical cancer or CIN3. We sought replication of candidate associations in FinnGen, a large independent dataset of 128 123 individuals. We also did a two-sample mendelian randomisation approach to explore the role of risk factors in the genetic risk of cervical cancer. FINDINGS: We included 4769 CIN3 and invasive cervical cancer case samples and 145 545 control samples in the GWAS. Of 9 600 464 assayed and imputed single-nucleotide polymorphisms (SNPs), six independent variants were associated with CIN3 and invasive cervical cancer. These included novel loci rs10175462 (PAX8; odds ratio [OR] 0·87, 95% CI 0·84-0·91; p=1·07 × 10-9) and rs27069 (CLPTM1L; 0·88, 0·84-0·92; p=2·51 × 10-9), and previously reported signals at rs9272050 (HLA-DQA1; 1·27, 1·21-1·32; p=2·51 × 10-28), rs6938453 (MICA; 0·79, 0·75-0·83; p=1·97 × 10-17), rs55986091 (HLA-DQB1; 0·66, 0·60-0·72; p=6·42 × 10-28), and rs9266183 (HLA-B; 0·73, 0·64-0·83; p=1·53 × 10-6). Three SNPs were replicated in the independent Finnish dataset of 1648 invasive cervical cancer cases: PAX8 (rs10175462; p=0·015), CLPTM1L (rs27069; p=2·54 × 10-7), and HLA-DQA1 (rs9272050; p=7·90 × 10-8). Mendelian randomisation further supported the complementary role of smoking (OR 2·46, 95% CI 1·64-3·69), older age at first pregnancy (0·80, 0·68-0·95), and number of sexual partners (1·95, 1·44-2·63) in the risk of developing cervical cancer. INTERPRETATION: Our results provide new evidence for the genetic susceptibility to cervical cancer, specifically the PAX8, CLPTM1L, and HLA genes, suggesting disruption in apoptotic and immune function pathways. Future studies integrating host and viral, genetic, and epigenetic variation, could further elucidate complex host-viral interactions. FUNDING: NIHR Imperial BRC Wellcome 4i Clinician Scientist Training Programme.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Bowden SJ, Bodinier B, Kalliala I, et al. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study. Lancet Oncol. 2021. PMID: 33794208. doi:10.1016/S1470-2045(21)00028-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。